Breast cancer vaccine BP1 7 - BiomiraAlternative Names: BLP16; BP1 7-KLH; Cancer vaccine BP1 7 - Biomira
Latest Information Update: 28 Jul 1999
At a glance
- Originator Biomira
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Breast cancer